期刊文献+

FBXO22基因在肾癌细胞侵袭中的作用及相关机制研究 被引量:3

Effects of FBXO22 gene in the migration of renal carcinoma cells and related molecular mechanisms
暂未订购
导出
摘要 目的:观察小干扰RNA(siRNA)沉默FBXO22基因对人肾癌细胞株(786-O、ACHN)细胞迁移、侵袭能力的影响。方法分别用siRNA-Ctrl和siRNA-FBXO22小干扰RNA转染人肾癌细胞株786-O和ACHN细胞;Western blot实验检测FBXO22蛋白表达量,CCK-8实验检测FBXO22基因对肾癌细胞增殖的影响,Transwell细胞迁移实验和侵袭实验检测沉默FBXO22基因后对786-O和ACHN肾癌细胞迁移能力和细胞侵袭能力的影响,明胶酶谱实验检测细胞分泌基质金属蛋白酶( MMPs)的能力。结果转染FBXO22 siRNA后肾癌786-O及ACHN细胞的FBXO22表达下调,迁移和侵袭能力提高,分泌MMP-9的能力升高,但对肾癌细胞增殖无影响。结论沉默FBXO22基因后,可以增加MMP-9的分泌,从而激活MMP-9信号通路增强肾癌786-O细胞及ACHN细胞的迁移和侵袭的能力。 Objective To investigate the effects of FBXO 22 silencing by small interfering RNA ( siRNA) on the mi-gration and invasion of human renal carcinoma 786-O cells and ACHN cells .Methods The siRNA-control and siR-NA-FBXO22 fragments were transfected into 786-O and ACHN cells .The level of FBXO22 was detected by Western blotting.The effects of FBXO22 silencing on cell proliferation were examined by CCK 8 assay.The effects of FBXO22 si-lencing on the migration and invasion of 786-O and ACHN cells were investigated by Transwell assay .The levels of ma-trix metalloproteinase ( MMPs) were detected by gelatin zymography .Results FBXO22 siRNA could down -regulated the level of FBXO22 in 786-O and ACHN cells, but stimulate the cells′capacities to migration and invasion and en-hance the secretion of MMP -2, without no influence on renal cancer cells .Conclusion FBXO22 silencing can stimu-late the secretion of MMP-9, which would then activate the migration and invasion of renal carcinoma cells .
出处 《徐州医学院学报》 CAS 2016年第3期141-145,共5页 Acta Academiae Medicinae Xuzhou
基金 基金项目:国家自然科学基金面上项目(81472663)
关键词 FBXO22 肾癌 迁移 侵袭 FBX022 renal cell carcinoma migration invasion
  • 相关文献

参考文献12

  • 1de Martino M, Leitner CV, Seemann C, et al. Preoperative serum cholesterol is an independent prognostic factor for patients with re- hal cell carcinoma (RCC) ~Jl. BJU Int, 2015,115(3) :397 - 404.
  • 2Breda A, Luearelli G, Rodriguez - Faba O, et al. Clinical and pathological outcomes of renal cell carcinoma (RCC) in native kidneys of patients with end - stage renal disease: a long - term comparative retrospective study with RCC diagnosed in the general population ~J]. World J Urol, 2015,33( 1 ) :1 -7.
  • 3Brugarolas J. Renal - cell carcinoma - - molecular pathways and therapies[J]. N Engl J Med, 2007, 356(2) : 185 -187.
  • 4Costantino C, Thomas GV, Ryan C, et al. Metastatic renal cell carcinoma without evidence of a renal primary [ J ]. Int Urel Neph- rol, 2016,48 ( 1 ) :73 - 77.
  • 5Chen J, Shen BY, Dang XX, et al. SKP1 - CULLIN1 - F - box (SCF) -mediated DRG2 degradation facilitated chemotherapeutic drugs induced apoptosis in hepatocellular carcinoma cells [ J ]. Biochem Biophys Res Commun, 2012,420 (3) :651 - 655.
  • 6Ho MS, Tsai PI, Chien CT. F - box proteins : the key to protein degradation [J]. J BiomedSci, 2006,13(2):181 -191.
  • 7Boehis OV, Fetiea B, Vlad C, et al. The importance of ubiquitin E3 ligases, SCF and APC/C, in human cancers [ J/OL]. Clujul Medical, 2015,88(1 ) :9 -14.
  • 8Tan MK, Lira HJ, Harper JW. CF ( FBXO22 ) regulates histone H3 lysine 9 and 36 methylation levels by targeting histone demeth- ylase KDM4A for ubiquitin - mediated proteasomal degradation [ J]. Mol Cell Biol, 2011,31 (18) :3687 -3699.
  • 9Campos EI, Reinberg D. Histones : annotating chromatin ~ J I. Annu Rev Genet, 2009,43:559 -599.
  • 10Fodor BD, Kubicek S, Yonezawa M, et al. Jmjd2b antagonizes H3K9 trimethylation at perieentrie heteroehromatin in mammalian cells [ J~. Genes Dev, 2006,20(12) :1557 - 1562.

同被引文献17

引证文献3

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部